No Data
No Data
Shattuck Labs Full Year 2024 Earnings: Misses Expectations
TD Cowen Maintains Shattuck Labs(STTK.US) With Buy Rating
Shattuck Labs' SL-325: Promising Preclinical Results and Growth Potential Justify Buy Rating
Needham Maintains Shattuck Labs(STTK.US) With Hold Rating
HC Wainwright & Co. Reiterates Neutral on Shattuck Labsto Neutral
Shattuck Labs: Hold Rating Due to Early Pipeline Stages and Lack of Near-Term Catalysts